Table of Contents Chapter 1 Overview of Leuprorelin 1.1 Definition of Leuprorelin in This Report 1.2 Commercial Types of Leuprorelin 1.2.1 <95% 1.2.2 95%-98% 1.2.3 >98% 1.3 Downstream Application of Leuprorelin 1.3.1 Medical Uses 1.3.2 Veterinary Uses 1.3.3 Other 1.4 Development History of Leuprorelin 1.5 Market Status and Trend of Leuprorelin 2013-2023 1.5.1 Global Leuprorelin Market Status and Trend 2013-2023 1.5.2 Regional Leuprorelin Market Status and Trend 2013-2023 Chapter 2 Global Market Status and Forecast by Regions 2.1 Market Development of Leuprorelin 2013-2017 2.2 Sales Market of Leuprorelin by Regions 2.2.1 Sales Volume of Leuprorelin by Regions 2.2.2 Sales Value of Leuprorelin by Regions 2.3 Production Market of Leuprorelin by Regions 2.4 Global Market Forecast of Leuprorelin 2018-2023 2.4.1 Global Market Forecast of Leuprorelin 2018-2023 2.4.2 Market Forecast of Leuprorelin by Regions 2018-2023 Chapter 3 Global Market Status and Forecast by Types 3.1 Sales Volume of Leuprorelin by Types 3.2 Sales Value of Leuprorelin by Types 3.3 Market Forecast of Leuprorelin by Types Chapter 4 Global Market Status and Forecast by Downstream Industry 4.1 Global Sales Volume of Leuprorelin by Downstream Industry 4.2 Global Market Forecast of Leuprorelin by Downstream Industry Chapter 5 North America Market Status by Countries, Type, Manufacturers and Downstream Industry 5.1 North America Leuprorelin Market Status by Countries 5.1.1 North America Leuprorelin Sales by Countries (2013-2017) 5.1.2 North America Leuprorelin Revenue by Countries (2013-2017) 5.1.3 United States Leuprorelin Market Status (2013-2017) 5.1.4 Canada Leuprorelin Market Status (2013-2017) 5.1.5 Mexico Leuprorelin Market Status (2013-2017) 5.2 North America Leuprorelin Market Status by Manufacturers 5.3 North America Leuprorelin Market Status by Type (2013-2017) 5.3.1 North America Leuprorelin Sales by Type (2013-2017) 5.3.2 North America Leuprorelin Revenue by Type (2013-2017) 5.4 North America Leuprorelin Market Status by Downstream Industry (2013-2017) Chapter 6 Europe Market Status by Countries, Type, Manufacturers and Downstream Industry 6.1 Europe Leuprorelin Market Status by Countries 6.1.1 Europe Leuprorelin Sales by Countries (2013-2017) 6.1.2 Europe Leuprorelin Revenue by Countries (2013-2017) 6.1.3 Germany Leuprorelin Market Status (2013-2017) 6.1.4 UK Leuprorelin Market Status (2013-2017) 6.1.5 France Leuprorelin Market Status (2013-2017) 6.1.6 Italy Leuprorelin Market Status (2013-2017) 6.1.7 Russia Leuprorelin Market Status (2013-2017) 6.1.8 Spain Leuprorelin Market Status (2013-2017) 6.1.9 Benelux Leuprorelin Market Status (2013-2017) 6.2 Europe Leuprorelin Market Status by Manufacturers 6.3 Europe Leuprorelin Market Status by Type (2013-2017) 6.3.1 Europe Leuprorelin Sales by Type (2013-2017) 6.3.2 Europe Leuprorelin Revenue by Type (2013-2017) 6.4 Europe Leuprorelin Market Status by Downstream Industry (2013-2017) Chapter 7 Asia Pacific Market Status by Countries, Type, Manufacturers and Downstream Industry 7.1 Asia Pacific Leuprorelin Market Status by Countries 7.1.1 Asia Pacific Leuprorelin Sales by Countries (2013-2017) 7.1.2 Asia Pacific Leuprorelin Revenue by Countries (2013-2017) 7.1.3 China Leuprorelin Market Status (2013-2017) 7.1.4 Japan Leuprorelin Market Status (2013-2017) 7.1.5 India Leuprorelin Market Status (2013-2017) 7.1.6 Southeast Asia Leuprorelin Market Status (2013-2017) 7.1.7 Australia Leuprorelin Market Status (2013-2017) 7.2 Asia Pacific Leuprorelin Market Status by Manufacturers 7.3 Asia Pacific Leuprorelin Market Status by Type (2013-2017) 7.3.1 Asia Pacific Leuprorelin Sales by Type (2013-2017) 7.3.2 Asia Pacific Leuprorelin Revenue by Type (2013-2017) 7.4 Asia Pacific Leuprorelin Market Status by Downstream Industry (2013-2017) Chapter 8 Latin America Market Status by Countries, Type, Manufacturers and Downstream Industry 8.1 Latin America Leuprorelin Market Status by Countries 8.1.1 Latin America Leuprorelin Sales by Countries (2013-2017) 8.1.2 Latin America Leuprorelin Revenue by Countries (2013-2017) 8.1.3 Brazil Leuprorelin Market Status (2013-2017) 8.1.4 Argentina Leuprorelin Market Status (2013-2017) 8.1.5 Colombia Leuprorelin Market Status (2013-2017) 8.2 Latin America Leuprorelin Market Status by Manufacturers 8.3 Latin America Leuprorelin Market Status by Type (2013-2017) 8.3.1 Latin America Leuprorelin Sales by Type (2013-2017) 8.3.2 Latin America Leuprorelin Revenue by Type (2013-2017) 8.4 Latin America Leuprorelin Market Status by Downstream Industry (2013-2017) Chapter 9 Middle East and Africa Market Status by Countries, Type, Manufacturers and Downstream Industry 9.1 Middle East and Africa Leuprorelin Market Status by Countries 9.1.1 Middle East and Africa Leuprorelin Sales by Countries (2013-2017) 9.1.2 Middle East and Africa Leuprorelin Revenue by Countries (2013-2017) 9.1.3 Middle East Leuprorelin Market Status (2013-2017) 9.1.4 Africa Leuprorelin Market Status (2013-2017) 9.2 Middle East and Africa Leuprorelin Market Status by Manufacturers 9.3 Middle East and Africa Leuprorelin Market Status by Type (2013-2017) 9.3.1 Middle East and Africa Leuprorelin Sales by Type (2013-2017) 9.3.2 Middle East and Africa Leuprorelin Revenue by Type (2013-2017) 9.4 Middle East and Africa Leuprorelin Market Status by Downstream Industry (2013-2017) Chapter 10 Market Driving Factor Analysis of Leuprorelin 10.1 Global Economy Situation and Trend Overview 10.2 Leuprorelin Downstream Industry Situation and Trend Overview Chapter 11 Leuprorelin Market Competition Status by Major Manufacturers 11.1 Production Volume of Leuprorelin by Major Manufacturers 11.2 Production Value of Leuprorelin by Major Manufacturers 11.3 Basic Information of Leuprorelin by Major Manufacturers 11.3.1 Headquarters Location and Established Time of Leuprorelin Major Manufacturer 11.3.2 Employees and Revenue Level of Leuprorelin Major Manufacturer 11.4 Market Competition News and Trend 11.4.1 Merger, Consolidation or Acquisition News 11.4.2 Investment or Disinvestment News 11.4.3 New Product Development and Launch Chapter 12 Leuprorelin Major Manufacturers Introduction and Market Data 12.1 Takeda Company 12.1.1 Company profile 12.1.2 Representative Leuprorelin Product 12.1.3 Leuprorelin Sales, Revenue, Price and Gross Margin of Takeda Company 12.2 Beijing Boente Pharmaceutical 12.2.1 Company profile 12.2.2 Representative Leuprorelin Product 12.2.3 Leuprorelin Sales, Revenue, Price and Gross Margin of Beijing Boente Pharmaceutical 12.3 Shanghai Livzon Pharmaceutical 12.3.1 Company profile 12.3.2 Representative Leuprorelin Product 12.3.3 Leuprorelin Sales, Revenue, Price and Gross Margin of Shanghai Livzon Pharmaceutical 12.4 Selleck China 12.4.1 Company profile 12.4.2 Representative Leuprorelin Product 12.4.3 Leuprorelin Sales, Revenue, Price and Gross Margin of Selleck China 12.5 Hangzhou Peptide Biochemical 12.5.1 Company profile 12.5.2 Representative Leuprorelin Product 12.5.3 Leuprorelin Sales, Revenue, Price and Gross Margin of Hangzhou Peptide Biochemical 12.6 Chengdu Shenguo Biological Pharmaceutical 12.6.1 Company profile 12.6.2 Representative Leuprorelin Product 12.6.3 Leuprorelin Sales, Revenue, Price and Gross Margin of Chengdu Shenguo Biological Pharmaceutical 12.7 Wuhan East Kangyuan Technology 12.7.1 Company profile 12.7.2 Representative Leuprorelin Product 12.7.3 Leuprorelin Sales, Revenue, Price and Gross Margin of Wuhan East Kangyuan Technology 12.8 Wuhan Mingye Technology Development 12.8.1 Company profile 12.8.2 Representative Leuprorelin Product 12.8.3 Leuprorelin Sales, Revenue, Price and Gross Margin of Wuhan Mingye Technology Development 12.9 Nanjing Peptide Industry Biotechnology 12.9.1 Company profile 12.9.2 Representative Leuprorelin Product 12.9.3 Leuprorelin Sales, Revenue, Price and Gross Margin of Nanjing Peptide Industry Biotechnology 12.10 Wuhan East Kangyuan Technology 12.10.1 Company profile 12.10.2 Representative Leuprorelin Product 12.10.3 Leuprorelin Sales, Revenue, Price and Gross Margin of Wuhan East Kangyuan Technology 12.11 Tianjin Takeda Pharmaceutical 12.11.1 Company profile 12.11.2 Representative Leuprorelin Product 12.11.3 Leuprorelin Sales, Revenue, Price and Gross Margin of Tianjin Takeda Pharmaceutical 12.12 Wuhan East Kangyuan Technology 12.12.1 Company profile 12.12.2 Representative Leuprorelin Product 12.12.3 Leuprorelin Sales, Revenue, Price and Gross Margin of Wuhan East Kangyuan Technology Chapter 13 Upstream and Downstream Market Analysis of Leuprorelin 13.1 Industry Chain of Leuprorelin 13.2 Upstream Market and Representative Companies Analysis 13.3 Downstream Market and Representative Companies Analysis Chapter 14 Cost and Gross Margin Analysis of Leuprorelin 14.1 Cost Structure Analysis of Leuprorelin 14.2 Raw Materials Cost Analysis of Leuprorelin 14.3 Labor Cost Analysis of Leuprorelin 14.4 Manufacturing Expenses Analysis of Leuprorelin Chapter 15 Report Conclusion Chapter 16 Research Methodology and Reference 16.1 Methodology/Research Approach 16.1.1 Research Programs/Design 16.1.2 Market Size Estimation 16.1.3 Market Breakdown and Data Triangulation 16.2 Data Source 16.2.1 Secondary Sources 16.2.2 Primary Sources 16.3 Reference

List of Tables Table Advantage and Disadvantage of <95% Table Advantage and Disadvantage of 95%-98% Table Advantage and Disadvantage of >98% Table Sales Volume of Leuprorelin by Regions 2013-2017 Table Sales Value of Leuprorelin by Regions 2013-2017 Table Production Volume of Leuprorelin by Regions 2013-2017 Table Global Sales Volume of Leuprorelin by Regions 2018-2023 Table Global Sales Value of Leuprorelin by Regions 2018-2023 Table Global Production Volume of Leuprorelin by Regions 2018-2023 Table Sales Volume of Leuprorelin by Types 2013-2017 Table Sales Value of Leuprorelin by Types 2013-2017 Table Sales Volume Forecast of Leuprorelin by Types 2018-2023 Table Sales Value Forecast of Leuprorelin by Types 2018-2023 Table Sales Volume of Leuprorelin by Downstream Industry 2013-2017 Table Sales Volume Forecast of Leuprorelin by Downstream Industry 2018-2023 Table North America Leuprorelin Sales by Countries (2013-2017) Table North America Leuprorelin Sales Share by Countries (2013-2017) Table North America Leuprorelin Revenue by Countries (2013-2017) Table North America Leuprorelin Revenue Market Share by Countries (2013-2017) Table North America Leuprorelin Sales by Type (2013-2017) Table North America Leuprorelin Sales Share by Type (2013-2017) Table North America Leuprorelin Revenue by Type (2013-2017) Table North America Leuprorelin Revenue Share by Type (2013-2017) Table North America Leuprorelin Sales by Downstream Industry (2013-2017) Table North America Leuprorelin Sales Share by Downstream Industry (2013-2017) Table Europe Leuprorelin Sales by Countries (2013-2017) Table Europe Leuprorelin Sales Share by Countries (2013-2017) Table Europe Leuprorelin Revenue by Countries (2013-2017) Table Europe Leuprorelin Revenue Market Share by Countries (2013-2017) Table Europe Leuprorelin Sales by Type (2013-2017) Table Europe Leuprorelin Sales Share by Type (2013-2017) Table Europe Leuprorelin Revenue by Type (2013-2017) Table Europe Leuprorelin Revenue Share by Type (2013-2017) Table Europe Leuprorelin Sales by Downstream Industry (2013-2017) Table Europe Leuprorelin Sales Share by Downstream Industry (2013-2017) Table Asia Pacific Leuprorelin Sales by Countries (2013-2017) Table Asia Pacific Leuprorelin Sales Share by Countries (2013-2017) Table Asia Pacific Leuprorelin Revenue by Countries (2013-2017) Table Asia Pacific Leuprorelin Revenue Market Share by Countries (2013-2017) Table Asia Pacific Leuprorelin Sales by Type (2013-2017) Table Asia Pacific Leuprorelin Sales Share by Type (2013-2017) Table Asia Pacific Leuprorelin Revenue by Type (2013-2017) Table Asia Pacific Leuprorelin Revenue Share by Type (2013-2017) Table Asia Pacific Leuprorelin Sales by Downstream Industry (2013-2017) Table Asia Pacific Leuprorelin Sales Share by Downstream Industry (2013-2017) Table Latin America Leuprorelin Sales by Countries (2013-2017) Table Latin America Leuprorelin Sales Share by Countries (2013-2017) Table Latin America Leuprorelin Revenue by Countries (2013-2017) Table Latin America Leuprorelin Revenue Market Share by Countries (2013-2017) Table Latin America Leuprorelin Sales by Type (2013-2017) Table Latin America Leuprorelin Sales Share by Type (2013-2017) Table Latin America Leuprorelin Revenue by Type (2013-2017) Table Latin America Leuprorelin Revenue Share by Type (2013-2017) Table Latin America Leuprorelin Sales by Downstream Industry (2013-2017) Table Latin America Leuprorelin Sales Share by Downstream Industry (2013-2017) Table Middle East and Africa Leuprorelin Sales by Regions (2013-2017) Table Middle East and Africa Leuprorelin Sales Share by Regions (2013-2017) Table Middle East and Africa Leuprorelin Revenue by Regions (2013-2017) Table Middle East and Africa Leuprorelin Revenue Market Share by Regions (2013-2017) Table Middle East and Africa Leuprorelin Sales by Type (2013-2017) Table Middle East and Africa Leuprorelin Sales Share by Type (2013-2017) Table Middle East and Africa Leuprorelin Revenue by Type (2013-2017) Table Middle East and Africa Leuprorelin Revenue Share by Type (2013-2017) Table Middle East and Africa Leuprorelin Sales by Downstream Industry (2013-2017) Table Middle East and Africa Leuprorelin Sales Share by Downstream Industry (2013-2017) Table Production Volume of Leuprorelin by Major Manufacturers 2013-2017 Table Production Value of Leuprorelin by Major Manufacturers 2013-2017 Table Headquarters Location and Established Time of Leuprorelin Major Manufacturer Table Employees and Revenue Level of Leuprorelin Major Manufacturer Table Representative Leuprorelin Product One of Takeda Company Table Representative Leuprorelin Product Two of Takeda Company Table Leuprorelin Sales, Revenue, Price and Gross Margin of Takeda Company 2013-2017 Table Representative Leuprorelin Product One of Beijing Boente Pharmaceutical Table Representative Leuprorelin Product Two of Beijing Boente Pharmaceutical Table Leuprorelin Sales, Revenue, Price and Gross Margin of Beijing Boente Pharmaceutical 2013-2017 Table Representative Leuprorelin Product One of Shanghai Livzon Pharmaceutical Table Representative Leuprorelin Product Two of Shanghai Livzon Pharmaceutical Table Leuprorelin Sales, Revenue, Price and Gross Margin of Shanghai Livzon Pharmaceutical 2013-2017 Table Representative Leuprorelin Product One of Selleck China Table Representative Leuprorelin Product Two of Selleck China Table Leuprorelin Sales, Revenue, Price and Gross Margin of Selleck China 2013-2017 Table Representative Leuprorelin Product One of Hangzhou Peptide Biochemical Table Representative Leuprorelin Product Two of Hangzhou Peptide Biochemical Table Leuprorelin Sales, Revenue, Price and Gross Margin of Hangzhou Peptide Biochemical 2013-2017 Table Representative Leuprorelin Product One of Chengdu Shenguo Biological Pharmaceutical Table Representative Leuprorelin Product Two of Chengdu Shenguo Biological Pharmaceutical Table Leuprorelin Sales, Revenue, Price and Gross Margin of Chengdu Shenguo Biological Pharmaceutical 2013-2017 Table Representative Leuprorelin Product One of Wuhan East Kangyuan Technology Table Representative Leuprorelin Product Two of Wuhan East Kangyuan Technology Table Leuprorelin Sales, Revenue, Price and Gross Margin of Wuhan East Kangyuan Technology 2013-2017 Table Representative Leuprorelin Product One of Wuhan Mingye Technology Development Table Representative Leuprorelin Product Two of Wuhan Mingye Technology Development Table Leuprorelin Sales, Revenue, Price and Gross Margin of Wuhan Mingye Technology Development 2013-2017 Table Representative Leuprorelin Product One of Nanjing Peptide Industry Biotechnology Table Representative Leuprorelin Product Two of Nanjing Peptide Industry Biotechnology Table Leuprorelin Sales, Revenue, Price and Gross Margin of Nanjing Peptide Industry Biotechnology 2013-2017 Table Representative Leuprorelin Product One of Wuhan East Kangyuan Technology Table Representative Leuprorelin Product Two of Wuhan East Kangyuan Technology Table Leuprorelin Sales, Revenue, Price and Gross Margin of Wuhan East Kangyuan Technology 2013-2017 Table Representative Leuprorelin Product One of Tianjin Takeda Pharmaceutical Table Representative Leuprorelin Product Two of Tianjin Takeda Pharmaceutical Table Leuprorelin Sales, Revenue, Price and Gross Margin of Tianjin Takeda Pharmaceutical 2013-2017 Table Representative Leuprorelin Product One of Wuhan East Kangyuan Technology Table Representative Leuprorelin Product Two of Wuhan East Kangyuan Technology Table Leuprorelin Sales, Revenue, Price and Gross Margin of Wuhan East Kangyuan Technology 2013-2017